Decrease in number of activated macrophages in demyelinated nerves subjected to 1hr ES. by Nikki A. McLean (643606)

“…Note: ES results in a significant decrease in the ED-1 IF 10d post-LPC (5d post-ES; K) and 12d post-LPC (7d post-ES; N) relative to LPC only in a pattern suggestive of movement toward lateral edges and egress (arrow). …”

19606 decreases the luminal pH of the ACV during infection. by Jesus S. Distel (11250759)

V5-SgG2 transfection in the epidermis modifies the termination site of peptidergic FNE. by Jorge Rubén Cabrera (685511)

Overview of sampling location, year, host plant, and presence of a functional <i>dim2</i> DNA methyltransferase gene of <i>Z</i>. <i>tritici</i> isolates analyzed in this study. by Mareike Möller (5548745)

Glu58 and Arg87 minimal distance decreases upon activation. by Maxime Louet (150102)

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

A multicopy <i>ASH1</i> plasmid increases <i>ASH1</i> mRNA and decreases <i>HO</i> mRNA levels. by Emily J. Parnell (6803422)

“…<i>ASH1</i> mRNA analysis under conditions of <i>ASH1</i> overexpression, using cell samples identical to those in <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1009133#pgen.1009133.g001" target="_blank">Fig 1E</a> (Tup1-V5 ChIP analysis). …”

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

Eltrombopag markedly decreases levels of ROS in MOLM14 cells. by Anna Kalota (7415)

“…B) Graphic presentation of ROS levels measured by flow cytometry in cells treated with E (5 μM) or DPI (25 μM), an inhibitor of NADPH oxidase known to decrease an intracellular level of ROS, or untreated (CTR) cells. …”

(A) Auxiliary marking points to ensure complete and accurate seating of the prosthesis. by Long Li (6555)

nanoDSF apparent melting points. by Aleksi Sutinen (10039145)

Subjects:

Compared to vorinostat, M344 decreases pancreatic cancer cell proliferation more effectively for a longer duration. by Shelby M. Knoche (13833807)

PGE₂ decreases <i>Sost</i> expression. by Damian C. Genetos (325684)

Activation, inactivation, and deactivation kinetics differ between Ca_V3.3 WT and variants as well as among the variants. by Yousra El Ghaleb (22075892)

Subjects:

Viral dissemination of HTLV-1_WT and HTLV-1_p12KO. by Ramona Moles (8153181)

Subjects:

Mutations in p38 MAP kinase components and the mucolipin ortholog CUP-5 suppress the decrease in abundance of EVA-1 in <i>madd-3</i> mutants. by Serena A. D’Souza (2635801)

Decrease in GABA_A immunoreactivity in APP mice. by Ksenia V. Kastanenka (3692380)

Sporulation is decreased in a Δ<i>mas</i> mutant. by Sarah Fremgen (102742)

A <i>mer2</i> point mutant affected for its interaction with Spp1 mimics the meiotic phenotype of <i>spp1∆</i>. by Céline Adam (320770)

ASO treatment suppresses the palbociclib-mediated induction of MEG3 and decrease in cell proliferation in A549 cells. by Traci L. Kruer (3342425)